Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis B

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

458 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

NCT00150098

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +21 more
Locations: New York Blood Center New York, United States

New York Blood Center - Project Achieve The Bronx, New York, United States

View Trial Details

Completed

Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants

NCT00401531

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +35 more
Locations: Bangkok, Thailand

Khonkaen, Thailand

View Trial Details

Completed

Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan

NCT01334567

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Kaoshiung Hsien, Taiwan

Tainan, Taiwan

Taipei, Taiwan

Taoyuan Hsien, Taiwan

View Trial Details

Completed

Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns

NCT01349283

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Center for Disease Control and Prevention Jiangsu Province Nanjing, Jiangsu, China

View Trial Details

Completed

Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®

NCT00362427

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Coquitlam, British Columbia, Canada

Surrey, British Columbia, Canada

Winnipeg, Manitoba, Canada

Halifax, Nova Scotia, Canada

View Trial Details

Completed

Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine

NCT00146835

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: Not specified

View Trial Details

Completed

Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

NCT00158717

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection

NCT01606163

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Department of clinical pharmacology and therapeutics Seoul, South Korea

View Trial Details

Completed

Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma

NCT02025842

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +18 more
Locations: Not specified

View Trial Details

Completed

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

NCT01590654

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

Indiana University Medical Center Indianapolis, Indiana, United States

Tulane University Health Sciences Center New Orleans, Louisiana, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View all 20 locations

View Trial Details